K. Howard
Molecular and Cellular Therapies · with Hvam · 2016
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom K. Howard trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Felix Kratz (in Radiology, Nuclear Medicine and Imaging)
Papers from K. Howard's perspective
Ordered by how strongly the researchers K. Howard trusts endorse each paper. Same corpus, a different order for every researcher.
- The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan (Journal of Experimental Medicine)
- Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. (Journal of Controlled Release)
- FcRn: the neonatal Fc receptor comes of age
- Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. (Clinical Cancer Research)
- Unraveling the mysteries of serum albumin—more than just a serum protein (Frontiers in Physiology)
- Impact of albumin on drug delivery--new applications on the horizon. (Journal of Controlled Release)
- Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. (Biological and Pharmaceutical Bulletin)
- Albumin: Biochemical properties and therapeutic potential (Hepatology)
- Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin (Journal of Biological Chemistry)
- Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines (Journal of drug targeting (Print))
Their papers
- Albumin-based drug delivery: harnessing nature to cure disease (2016) — 596 citations